September 15, 2026 - 03:36

Anna Dodson has joined Foley Hoag's Boston office, stepping into the role of co-chair of the debt finance practice. With a wealth of experience in the field, Dodson's arrival is expected to bolster the firm's capabilities in serving clients with complex financing needs. Her background includes a strong focus on structuring and negotiating various debt transactions, making her a valuable asset to the team.
Dodson's expertise spans a wide range of sectors, allowing her to navigate the intricacies of debt finance with ease. Her track record includes advising both borrowers and lenders, which positions her to provide comprehensive guidance to clients at Foley Hoag. As the demand for debt financing continues to grow, her leadership is likely to enhance the firm's reputation and expand its client base.
Foley Hoag is optimistic about the contributions Dodson will bring, particularly in a market that requires innovative solutions and strategic thinking. Her appointment underscores the firm's commitment to excellence in debt finance.
September 14, 2026 - 04:45
Intuit Targets New Customers, AI Growth as QuickBooks and TurboTax Bets ScaleIntuit is placing a sharper focus on bringing in first-time customers while it continues to grow its largest business lines, according to comments made by Chief Financial Officer Sandeep Singh...
September 13, 2026 - 08:33
$10,000 in Tesla When It Joined the S&P 500 Would Be About $15,700 Today. An Index Fund Would Have Done Better.When Tesla joined the S&P 500 in December 2020, index funds were forced to buy the stock at a record price of $695 a share. Investors who put $10,000 into Tesla at that moment would have roughly...
September 12, 2026 - 21:35
Hershey’s Dividend Is Finally Growing Again After a Nearly 2-Year FreezeHershey has ended a nearly two-year freeze on its quarterly dividend, raising the payout for the first time since the company paused increases. The move comes after five consecutive cycles without...
September 12, 2026 - 09:23
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial NearsTonix Pharmaceuticals is putting commercial execution at the center of its strategy as it prepares to bring TONMYA to the market. CEO Seth Lederman, speaking at the Cantor Healthcare Conference,...